Drug Profile
Research programme: non-opioid pain therapeutics - Grunenthal/Katholieke Universiteit Leuven
Alternative Names: Transient receptor potential channel modulators - Grunenthal/Katholieke Universiteit Leuven; Transient receptor potential channel modulators - Katholieke Universiteit Leuven/Grunenthal; TRP channel modulators - Grunenthal/Katholieke Universiteit Leuven; TRP channel modulators - Katholieke Universiteit Leuven/GrunenthalLatest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator Grunenthal; Katholieke Universiteit Leuven
- Developer Katholieke Universiteit Leuven
- Class
- Mechanism of Action Transient receptor potential channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 May 2022 No recent reports of development identified for research development in Pain in Belgium
- 28 May 2022 No recent reports of development identified for research development in Pain in Germany
- 09 Apr 2018 Grünenthal and the Katholieke Universiteit Leuven enter into a research a research collaboration for the development of non-opioid therapeutics for Pain